vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.

Immunocore Holdings plc is the larger business by last-quarter revenue ($104.5M vs $56.8M, roughly 1.8× Star Equity Holdings, Inc.). On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs 24.3%). Star Equity Holdings, Inc. produced more free cash flow last quarter ($-9.0M vs $-35.5M). Over the past eight quarters, Star Equity Holdings, Inc.'s revenue compounded faster (29.5% CAGR vs 21.7%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

IMCR vs STRR — Head-to-Head

Bigger by revenue
IMCR
IMCR
1.8× larger
IMCR
$104.5M
$56.8M
STRR
Growing faster (revenue YoY)
STRR
STRR
+44.7% gap
STRR
69.0%
24.3%
IMCR
More free cash flow
STRR
STRR
$26.6M more FCF
STRR
$-9.0M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
STRR
STRR
Annualised
STRR
29.5%
21.7%
IMCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
STRR
STRR
Revenue
$104.5M
$56.8M
Net Profit
$-1.7M
Gross Margin
97.4%
Operating Margin
-18.8%
-0.2%
Net Margin
-3.0%
Revenue YoY
24.3%
69.0%
Net Profit YoY
-192.1%
EPS (diluted)
$-0.61
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
STRR
STRR
Q4 25
$104.5M
$56.8M
Q3 25
$103.7M
$48.0M
Q2 25
$98.0M
$35.5M
Q1 25
$93.9M
$31.9M
Q4 24
$84.1M
$33.6M
Q3 24
$80.2M
$36.9M
Q2 24
$75.4M
$35.7M
Q1 24
$70.5M
$33.9M
Net Profit
IMCR
IMCR
STRR
STRR
Q4 25
$-1.7M
Q3 25
$-177.0K
$-1.8M
Q2 25
$-10.3M
$-688.0K
Q1 25
$5.0M
$-1.8M
Q4 24
$-585.0K
Q3 24
$8.7M
$-846.0K
Q2 24
$-11.6M
$-441.0K
Q1 24
$-24.4M
$-2.9M
Gross Margin
IMCR
IMCR
STRR
STRR
Q4 25
97.4%
Q3 25
99.5%
43.0%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
50.5%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
STRR
STRR
Q4 25
-18.8%
-0.2%
Q3 25
-6.9%
-3.4%
Q2 25
-15.2%
-0.6%
Q1 25
-3.9%
-5.4%
Q4 24
-23.1%
-0.4%
Q3 24
-10.6%
-1.2%
Q2 24
-21.2%
-0.5%
Q1 24
-37.6%
-9.0%
Net Margin
IMCR
IMCR
STRR
STRR
Q4 25
-3.0%
Q3 25
-0.2%
-3.7%
Q2 25
-10.5%
-1.9%
Q1 25
5.4%
-5.5%
Q4 24
-1.7%
Q3 24
10.9%
-2.3%
Q2 24
-15.4%
-1.2%
Q1 24
-34.7%
-8.6%
EPS (diluted)
IMCR
IMCR
STRR
STRR
Q4 25
$-0.61
$-0.49
Q3 25
$0.00
$-0.54
Q2 25
$-0.20
$-0.23
Q1 25
$0.10
$-0.59
Q4 24
$-0.47
$-0.21
Q3 24
$0.17
$-0.28
Q2 24
$-0.23
$-0.15
Q1 24
$-0.49
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
STRR
STRR
Cash + ST InvestmentsLiquidity on hand
$864.2M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$65.7M
Total Assets
$1.1B
$113.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
STRR
STRR
Q4 25
$864.2M
$10.3M
Q3 25
$892.4M
$15.4M
Q2 25
$882.8M
$16.8M
Q1 25
$837.0M
$16.6M
Q4 24
$820.4M
$17.0M
Q3 24
$901.3M
$15.8M
Q2 24
$859.6M
$14.7M
Q1 24
$832.8M
$20.4M
Total Debt
IMCR
IMCR
STRR
STRR
Q4 25
Q3 25
$6.5M
Q2 25
Q1 25
Q4 24
$0
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
STRR
STRR
Q4 25
$381.0M
$65.7M
Q3 25
$396.6M
$67.8M
Q2 25
$388.5M
$40.1M
Q1 25
$378.5M
$39.5M
Q4 24
$360.7M
$40.4M
Q3 24
$377.8M
$42.9M
Q2 24
$359.1M
$42.6M
Q1 24
$359.5M
$44.3M
Total Assets
IMCR
IMCR
STRR
STRR
Q4 25
$1.1B
$113.2M
Q3 25
$1.1B
$117.1M
Q2 25
$1.1B
$55.6M
Q1 25
$1.0B
$53.2M
Q4 24
$1.0B
$52.6M
Q3 24
$1.1B
$52.6M
Q2 24
$1.0B
$52.6M
Q1 24
$994.0M
$52.6M
Debt / Equity
IMCR
IMCR
STRR
STRR
Q4 25
Q3 25
0.10×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
STRR
STRR
Operating Cash FlowLast quarter
$-32.7M
$-7.3M
Free Cash FlowOCF − Capex
$-35.5M
$-9.0M
FCF MarginFCF / Revenue
-34.0%
-15.8%
Capex IntensityCapex / Revenue
2.8%
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
STRR
STRR
Q4 25
$-32.7M
$-7.3M
Q3 25
$-4.5M
$-2.7M
Q2 25
$26.0M
$139.0K
Q1 25
$435.0K
$-802.0K
Q4 24
$-14.0M
$-2.8M
Q3 24
$21.1M
$1.3M
Q2 24
$23.5M
$-4.3M
Q1 24
$-4.6M
$-1.8M
Free Cash Flow
IMCR
IMCR
STRR
STRR
Q4 25
$-35.5M
$-9.0M
Q3 25
$-5.2M
$-3.4M
Q2 25
$25.6M
$102.0K
Q1 25
$137.0K
$-808.0K
Q4 24
$-17.5M
$-2.8M
Q3 24
$20.3M
$1.3M
Q2 24
$23.1M
$-4.3M
Q1 24
$-5.0M
$-1.8M
FCF Margin
IMCR
IMCR
STRR
STRR
Q4 25
-34.0%
-15.8%
Q3 25
-5.0%
-7.0%
Q2 25
26.1%
0.3%
Q1 25
0.1%
-2.5%
Q4 24
-20.9%
-8.3%
Q3 24
25.3%
3.4%
Q2 24
30.7%
-12.0%
Q1 24
-7.1%
-5.3%
Capex Intensity
IMCR
IMCR
STRR
STRR
Q4 25
2.8%
3.0%
Q3 25
0.7%
1.3%
Q2 25
0.4%
0.1%
Q1 25
0.3%
0.0%
Q4 24
4.3%
0.1%
Q3 24
1.0%
0.0%
Q2 24
0.4%
0.0%
Q1 24
0.6%
0.0%
Cash Conversion
IMCR
IMCR
STRR
STRR
Q4 25
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

Related Comparisons